Partner Investment Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Partner Investment Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-26,066	Closed	-$1.19M	–	102
2017 Q4	$1.19M	Buy	26,066 +6,258	+32%	+$312K	1.37%	30
2017 Q3	$889K	Buy	+19,808	New	+$675K	0.84%	44
2016 Q4	–	Sell	-18,376	Closed	-$551K	–	119
2016 Q3	$551K	Buy	+18,376	New	+$572K	0.82%	48
2016 Q1	–	Sell	-953	Closed	-$42K	–	97
2015 Q4	$42K	Buy	+953	New	+$47.3K	0.07%	62
2015 Q3	–	Sell	-10,194	Closed	-$544K	–	105
2015 Q2	$544K	Sell	10,194 -7,838	-43%	-$416K	0.77%	48
2015 Q1	$1M	Sell	18,032 -5,448	-23%	-$264K	1.51%	23
2014 Q4	$1.23M	Buy	+23,480	New	+$1.05M	0.5%	48

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Partner Investment Management's JUNO Position: Q1 2018 in Review

Partner Investment Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 26,066 shares — an estimated $1.19M sold.

Partner Investment Management first reported a position in JUNO in Q4 2014 and held it in 7 quarters. The position peaked at $1.23M in Q4 2014. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Partner Investment Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Partner Investment Management sold 26,066 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.19M.
Partner Investment Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 7 quarters.
Partner Investment Management's Juno Therapeutics, Inc. position peaked at $1.23M in Q4 2014.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Partner Investment Management's 13F filing for Q1 2018, filed 15 May 2018.